Singapore Study Finds Cancer Patients On TKIs Four Times More Likely To Develop Severe Liver Toxicity
This article was originally published in PharmAsia News
Executive Summary
Researchers hope to build on meta-analysis of tyrosine kinase inhibitors with clinical studies that explore the role of genetics.